<p>0.2 mM MOG (hatched bar) increased basal (2 mM glucose) insulin secretion from INS-1 cells 2.5-fold while 12 mM glucose resulted in a 3.5-fold increase (first black bar). The effect of the DG kinase inhibitor R59949 to stimulate basal insulin secretion (white bars) was small and inconsistent over the concentration range tested (0.25–10 µM) compared to the MOG-stimulated increase in basal release (hatched bar). R59949 increased glucose-stimulated insulin release 2-fold at low concentration (0.25 µM) with higher concentrations (1–10 µM) having no stimulatory effect compared to the control (black bars). N = 9 from 3 separate experiments. *p<0.05; **p<0.005 compared to control basal value. #p<0.005 compared to high glucose control.</p
Chronic hyperglycemia impairs insulin action, resulting in glucotoxicity, which can be ameliorated i...
<p>Differentiated SGBS adipocytes were pre-treated for 30 min with or without 1 μM propranolol prior...
<p>(A) Insulin secretion at 2.8 mM glucose measured in the presence of rosuvastatin (Ros) at concent...
<p>A. 200 µM MOG did not increase cytosolic Ca<sup>2+</sup> in dissociated rat islet cells. Arrows i...
<p>A. Long-term exposure to 11 mM glucose and either 0.16 mM or 0.3 mM oleate complexed to FBS (FA) ...
<p>A. 3 mM NAC (black bars) inhibited 10 mM ß-OHB-, 100 µM MOG- and 8 mM glucose-stimulated insulin ...
<p>A. 200 µM MOG increased basal (2 mM glucose) insulin secretion from INS-1 cells in a time-depende...
<p>(A) Glucose stimulation for 30 minutes induces insulin secretion in control cells (Uninfected and...
<p>(<i>A</i>) Insulin release was tested during a 30 min exposure to either 2.8 mM (<i>left panel</i...
Although chronic hyperglycemia reduces insulin sensitivity and leads to impaired glucose utilization...
AIM: To determine whether the excretion of glucose improves insulin resistance, impaired insulin sec...
Copyright © 2013 Min-Chuan Lai et al. This is an open access article distributed under the Creative ...
<p>Differentiated human subcutaneous SGBS adipocytes <b>(A)</b> and visceral LiSa-2 adipocytes <b>(B...
<p>L6 cells were maintained in normal-glucose (5 mM) or high-glucose (25 mM) medium. Cells were trea...
<p>BRIN-BD11 cells were cultured, allowed to adhere overnight prior to being pre-incubated (40 min) ...
Chronic hyperglycemia impairs insulin action, resulting in glucotoxicity, which can be ameliorated i...
<p>Differentiated SGBS adipocytes were pre-treated for 30 min with or without 1 μM propranolol prior...
<p>(A) Insulin secretion at 2.8 mM glucose measured in the presence of rosuvastatin (Ros) at concent...
<p>A. 200 µM MOG did not increase cytosolic Ca<sup>2+</sup> in dissociated rat islet cells. Arrows i...
<p>A. Long-term exposure to 11 mM glucose and either 0.16 mM or 0.3 mM oleate complexed to FBS (FA) ...
<p>A. 3 mM NAC (black bars) inhibited 10 mM ß-OHB-, 100 µM MOG- and 8 mM glucose-stimulated insulin ...
<p>A. 200 µM MOG increased basal (2 mM glucose) insulin secretion from INS-1 cells in a time-depende...
<p>(A) Glucose stimulation for 30 minutes induces insulin secretion in control cells (Uninfected and...
<p>(<i>A</i>) Insulin release was tested during a 30 min exposure to either 2.8 mM (<i>left panel</i...
Although chronic hyperglycemia reduces insulin sensitivity and leads to impaired glucose utilization...
AIM: To determine whether the excretion of glucose improves insulin resistance, impaired insulin sec...
Copyright © 2013 Min-Chuan Lai et al. This is an open access article distributed under the Creative ...
<p>Differentiated human subcutaneous SGBS adipocytes <b>(A)</b> and visceral LiSa-2 adipocytes <b>(B...
<p>L6 cells were maintained in normal-glucose (5 mM) or high-glucose (25 mM) medium. Cells were trea...
<p>BRIN-BD11 cells were cultured, allowed to adhere overnight prior to being pre-incubated (40 min) ...
Chronic hyperglycemia impairs insulin action, resulting in glucotoxicity, which can be ameliorated i...
<p>Differentiated SGBS adipocytes were pre-treated for 30 min with or without 1 μM propranolol prior...
<p>(A) Insulin secretion at 2.8 mM glucose measured in the presence of rosuvastatin (Ros) at concent...